Clinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis.

Authors:
Kim YH; Kim SI; Park B; Lee ES.

Journal:
Ann Dermatol

Publication Year: 2023

DOI:
10.5021/ad.22.148

PMCID:
PMC10112364

PMID:
37041707

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Dermatol

Abbreviation: Ann Dermatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Case of Multiple Apocrine Hidrocystomas Accompanied by Inflammation on Bilateral Axillae.
Choi S; Lew BL; Kwon SH. (2024) - Transparency Score: 3/6
A Comparative Study on Clinico-Histopathological Features of Granulomatous Rosacea and Lupus Miliar…
Park SH; Ahn SW; Jang SH and 5 more (2024) - Transparency Score: 3/6
Eyelash Dyeing for Poliosis of Eyelashes in Patients With Vitiligo.
Ju HJ; Kim SH; Lee SG and 1 more (2024) - Transparency Score: 3/6
<i>Actinidia polygama</i> Water Extract (APWE) Protects Against UVB-Induced Photoaging via MAPK/AP-…
Lee JM; Park SJ; Kim YJ and 8 more (2024) - Transparency Score: 3/6
Multi-Site Microbiome Composition in Atopic Dermatitis: A Case-Control Study.
Pitlick MM; Johnson S; Mullakary RM and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: Eun-So Lee received grants for clinical research from AbbVie, Inc., Celgene Corporation, Cell Biotech, Lilly, Janssen Pharmaceuticals, Inc., Samsung Bioepis and Servier; served as an advisor or consultant for AbbVie, Inc., Celgene Corporation, Galderma Korea, Janssen Pharmaceuticals, Inc., Lilly, and Novartis Pharmaceutical Corporation. There are no conflicts of interest to disclose relevant to this manuscript."

Evidence found in paper:

"FUNDING SOURCE: This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025